0001209191-20-009807.txt : 20200214
0001209191-20-009807.hdr.sgml : 20200214
20200214183943
ACCESSION NUMBER: 0001209191-20-009807
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200212
FILED AS OF DATE: 20200214
DATE AS OF CHANGE: 20200214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Janssen Robert
CENTRAL INDEX KEY: 0001580849
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 20622542
MAIL ADDRESS:
STREET 1: C/O DYNAVAX TECHNOLOGIES
STREET 2: 2929 SEVENTH STREET, SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 SEVENTH STREET
STREET 2: SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2929 SEVENTH STREET
STREET 2: SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-12
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001580849
Janssen Robert
C/O DYNAVAX TECHNOLOGIES
2100 POWELL STREET, SUITE 900
EMERYVILLE
CA
94608
0
1
0
0
Senior Vice President
Common Stock
2020-02-12
4
M
0
26000
A
220680
D
Stock Option (Right to Buy)
5.42
2020-02-12
4
A
0
105000
0.00
A
2027-02-11
Common Stock
105000
105000
D
Restricted Stock Unit
2020-02-12
4
M
0
26000
A
Common Stock
26000
0
D
Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock that vested and converted to common stock on February 12, 2020.
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date, and one thirty-sixth (1/36) of the shares subject to the option
vesting on the last day of each month thereafter.
/s/ Robert Janssen
2020-02-14